nodes	percent_of_prediction	percent_of_DWPC	metapath
Indapamide—KCNE1—renal system—urinary bladder cancer	0.0161	0.0837	CbGeAlD
Indapamide—KCNE1—female reproductive system—urinary bladder cancer	0.0129	0.067	CbGeAlD
Indapamide—KCNQ1—prostate gland—urinary bladder cancer	0.0109	0.0564	CbGeAlD
Indapamide—CA5A—female reproductive system—urinary bladder cancer	0.00979	0.0508	CbGeAlD
Indapamide—KCNQ1—seminal vesicle—urinary bladder cancer	0.00919	0.0477	CbGeAlD
Indapamide—CA7—renal system—urinary bladder cancer	0.00813	0.0422	CbGeAlD
Indapamide—SLC12A3—renal system—urinary bladder cancer	0.00797	0.0413	CbGeAlD
Indapamide—KCNQ1—renal system—urinary bladder cancer	0.00741	0.0384	CbGeAlD
Indapamide—KCNQ1—urethra—urinary bladder cancer	0.00728	0.0377	CbGeAlD
Indapamide—CYP3A4—urine—urinary bladder cancer	0.00715	0.0371	CbGeAlD
Indapamide—CA5B—prostate gland—urinary bladder cancer	0.00695	0.0361	CbGeAlD
Indapamide—SLC12A3—female reproductive system—urinary bladder cancer	0.00638	0.0331	CbGeAlD
Indapamide—KCNQ1—female reproductive system—urinary bladder cancer	0.00593	0.0308	CbGeAlD
Indapamide—CA9—female reproductive system—urinary bladder cancer	0.00572	0.0297	CbGeAlD
Indapamide—CA12—renal system—urinary bladder cancer	0.00528	0.0274	CbGeAlD
Indapamide—CA4—prostate gland—urinary bladder cancer	0.0048	0.0249	CbGeAlD
Indapamide—CA5B—urethra—urinary bladder cancer	0.00466	0.0242	CbGeAlD
Indapamide—CA12—female reproductive system—urinary bladder cancer	0.00423	0.022	CbGeAlD
Indapamide—CA4—seminal vesicle—urinary bladder cancer	0.00406	0.0211	CbGeAlD
Indapamide—CA2—prostate gland—urinary bladder cancer	0.00398	0.0206	CbGeAlD
Indapamide—CA5B—female reproductive system—urinary bladder cancer	0.0038	0.0197	CbGeAlD
Indapamide—KCNQ1—lymph node—urinary bladder cancer	0.00347	0.018	CbGeAlD
Indapamide—CA5B—vagina—urinary bladder cancer	0.00343	0.0178	CbGeAlD
Indapamide—CA2—seminal vesicle—urinary bladder cancer	0.00337	0.0175	CbGeAlD
Indapamide—CA4—renal system—urinary bladder cancer	0.00327	0.017	CbGeAlD
Indapamide—CA4—urethra—urinary bladder cancer	0.00321	0.0167	CbGeAlD
Indapamide—CA2—epithelium—urinary bladder cancer	0.00293	0.0152	CbGeAlD
Indapamide—CA2—smooth muscle tissue—urinary bladder cancer	0.00282	0.0146	CbGeAlD
Indapamide—CA2—renal system—urinary bladder cancer	0.00271	0.0141	CbGeAlD
Indapamide—CA4—female reproductive system—urinary bladder cancer	0.00262	0.0136	CbGeAlD
Indapamide—CA5B—lymph node—urinary bladder cancer	0.00222	0.0115	CbGeAlD
Indapamide—CA2—female reproductive system—urinary bladder cancer	0.00217	0.0113	CbGeAlD
Indapamide—CA2—vagina—urinary bladder cancer	0.00197	0.0102	CbGeAlD
Indapamide—CYP3A4—renal system—urinary bladder cancer	0.00175	0.00908	CbGeAlD
Indapamide—CA4—lymph node—urinary bladder cancer	0.00153	0.00795	CbGeAlD
Indapamide—CYP3A4—female reproductive system—urinary bladder cancer	0.0014	0.00727	CbGeAlD
Indapamide—CA2—lymph node—urinary bladder cancer	0.00127	0.00659	CbGeAlD
Indapamide—CYP3A4—Oxidation by Cytochrome P450—CYP4B1—urinary bladder cancer	0.000652	0.0028	CbGpPWpGaD
Indapamide—SLC12A3—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000633	0.00272	CbGpPWpGaD
Indapamide—CA5A—Metabolism—GSTO2—urinary bladder cancer	0.000629	0.00271	CbGpPWpGaD
Indapamide—CA5A—Metabolism—NAT1—urinary bladder cancer	0.000629	0.00271	CbGpPWpGaD
Indapamide—CA7—Metabolism—GSTZ1—urinary bladder cancer	0.00062	0.00266	CbGpPWpGaD
Indapamide—CA5B—Metabolism—GSTZ1—urinary bladder cancer	0.00062	0.00266	CbGpPWpGaD
Indapamide—KCNQ1—SIDS Susceptibility Pathways—EP300—urinary bladder cancer	0.000609	0.00262	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—RBX1—urinary bladder cancer	0.000605	0.0026	CbGpPWpGaD
Indapamide—CA7—Metabolism—GSTO2—urinary bladder cancer	0.000588	0.00253	CbGpPWpGaD
Indapamide—CA5B—Metabolism—GSTO2—urinary bladder cancer	0.000588	0.00253	CbGpPWpGaD
Indapamide—CA7—Metabolism—NAT1—urinary bladder cancer	0.000588	0.00253	CbGpPWpGaD
Indapamide—CA5B—Metabolism—NAT1—urinary bladder cancer	0.000588	0.00253	CbGpPWpGaD
Indapamide—CA5A—Metabolism—UGT2B7—urinary bladder cancer	0.000576	0.00247	CbGpPWpGaD
Indapamide—CA12—Metabolism—GSTZ1—urinary bladder cancer	0.000574	0.00247	CbGpPWpGaD
Indapamide—CYP3A4—Estrogen metabolism—GSTM1—urinary bladder cancer	0.000568	0.00244	CbGpPWpGaD
Indapamide—CA9—HIF-1-alpha transcription factor network—EP300—urinary bladder cancer	0.00056	0.00241	CbGpPWpGaD
Indapamide—CA12—Metabolism—NAT1—urinary bladder cancer	0.000544	0.00234	CbGpPWpGaD
Indapamide—CA12—Metabolism—GSTO2—urinary bladder cancer	0.000544	0.00234	CbGpPWpGaD
Indapamide—CA5B—Metabolism—UGT2B7—urinary bladder cancer	0.000537	0.00231	CbGpPWpGaD
Indapamide—CA7—Metabolism—UGT2B7—urinary bladder cancer	0.000537	0.00231	CbGpPWpGaD
Indapamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP4B1—urinary bladder cancer	0.000535	0.0023	CbGpPWpGaD
Indapamide—CYP3A4—Constitutive Androstane Receptor Pathway—SMC1A—urinary bladder cancer	0.000533	0.00229	CbGpPWpGaD
Indapamide—CA5A—Metabolism—CYP4B1—urinary bladder cancer	0.000518	0.00223	CbGpPWpGaD
Indapamide—CA12—Metabolism—UGT2B7—urinary bladder cancer	0.000498	0.00214	CbGpPWpGaD
Indapamide—KCNQ1—SIDS Susceptibility Pathways—TNF—urinary bladder cancer	0.000495	0.00213	CbGpPWpGaD
Indapamide—CA5A—Metabolism—SLC19A1—urinary bladder cancer	0.000489	0.0021	CbGpPWpGaD
Indapamide—CA5B—Metabolism—CYP4B1—urinary bladder cancer	0.000484	0.00208	CbGpPWpGaD
Indapamide—CA7—Metabolism—CYP4B1—urinary bladder cancer	0.000484	0.00208	CbGpPWpGaD
Indapamide—CA5A—Metabolism—PRSS3—urinary bladder cancer	0.000477	0.00205	CbGpPWpGaD
Indapamide—CA4—Metabolism—GSTZ1—urinary bladder cancer	0.000458	0.00197	CbGpPWpGaD
Indapamide—CA5B—Metabolism—SLC19A1—urinary bladder cancer	0.000457	0.00196	CbGpPWpGaD
Indapamide—CA7—Metabolism—SLC19A1—urinary bladder cancer	0.000457	0.00196	CbGpPWpGaD
Indapamide—CA12—Metabolism—CYP4B1—urinary bladder cancer	0.000448	0.00193	CbGpPWpGaD
Indapamide—CA7—Metabolism—PRSS3—urinary bladder cancer	0.000445	0.00191	CbGpPWpGaD
Indapamide—CA5B—Metabolism—PRSS3—urinary bladder cancer	0.000445	0.00191	CbGpPWpGaD
Indapamide—CA2—Metabolism—GSTZ1—urinary bladder cancer	0.000439	0.00189	CbGpPWpGaD
Indapamide—CA4—Metabolism—GSTO2—urinary bladder cancer	0.000434	0.00187	CbGpPWpGaD
Indapamide—CA4—Metabolism—NAT1—urinary bladder cancer	0.000434	0.00187	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—GSTP1—urinary bladder cancer	0.000429	0.00184	CbGpPWpGaD
Indapamide—SLC12A3—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000428	0.00184	CbGpPWpGaD
Indapamide—CA12—Metabolism—SLC19A1—urinary bladder cancer	0.000423	0.00182	CbGpPWpGaD
Indapamide—CA2—Metabolism—GSTO2—urinary bladder cancer	0.000416	0.00179	CbGpPWpGaD
Indapamide—CA2—Metabolism—NAT1—urinary bladder cancer	0.000416	0.00179	CbGpPWpGaD
Indapamide—CA12—Metabolism—PRSS3—urinary bladder cancer	0.000413	0.00177	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—CCNE1—urinary bladder cancer	0.000406	0.00174	CbGpPWpGaD
Indapamide—CA4—Metabolism—UGT2B7—urinary bladder cancer	0.000397	0.00171	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—SOD2—urinary bladder cancer	0.000395	0.0017	CbGpPWpGaD
Indapamide—CA5A—Metabolism—TYMP—urinary bladder cancer	0.000381	0.00164	CbGpPWpGaD
Indapamide—CA2—Metabolism—UGT2B7—urinary bladder cancer	0.000381	0.00164	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—GPX1—urinary bladder cancer	0.000377	0.00162	CbGpPWpGaD
Indapamide—CA9—Metabolism—GSTZ1—urinary bladder cancer	0.00037	0.00159	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—GSTZ1—urinary bladder cancer	0.000364	0.00157	CbGpPWpGaD
Indapamide—CYP3A4—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.000359	0.00154	CbGpPWpGaD
Indapamide—CA4—Metabolism—CYP4B1—urinary bladder cancer	0.000357	0.00154	CbGpPWpGaD
Indapamide—CA7—Metabolism—TYMP—urinary bladder cancer	0.000356	0.00153	CbGpPWpGaD
Indapamide—CA5B—Metabolism—TYMP—urinary bladder cancer	0.000356	0.00153	CbGpPWpGaD
Indapamide—CA9—Metabolism—GSTO2—urinary bladder cancer	0.000351	0.00151	CbGpPWpGaD
Indapamide—CA9—Metabolism—NAT1—urinary bladder cancer	0.000351	0.00151	CbGpPWpGaD
Indapamide—Pruritus—Fluorouracil—urinary bladder cancer	0.000346	0.000603	CcSEcCtD
Indapamide—Drowsiness—Doxorubicin—urinary bladder cancer	0.000346	0.000602	CcSEcCtD
Indapamide—Visual impairment—Methotrexate—urinary bladder cancer	0.000345	0.000601	CcSEcCtD
Indapamide—CYP3A4—Biological oxidations—GSTO2—urinary bladder cancer	0.000345	0.00148	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—NAT1—urinary bladder cancer	0.000345	0.00148	CbGpPWpGaD
Indapamide—CA5A—Metabolism—NAT2—urinary bladder cancer	0.000345	0.00148	CbGpPWpGaD
Indapamide—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	0.000343	0.000596	CcSEcCtD
Indapamide—CA2—Metabolism—CYP4B1—urinary bladder cancer	0.000343	0.00147	CbGpPWpGaD
Indapamide—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000342	0.000595	CcSEcCtD
Indapamide—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000341	0.000593	CcSEcCtD
Indapamide—CYP3A4—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.000341	0.00146	CbGpPWpGaD
Indapamide—Renal failure—Doxorubicin—urinary bladder cancer	0.00034	0.000591	CcSEcCtD
Indapamide—Erythema multiforme—Methotrexate—urinary bladder cancer	0.000339	0.00059	CcSEcCtD
Indapamide—Urticaria—Etoposide—urinary bladder cancer	0.000338	0.000588	CcSEcCtD
Indapamide—CA4—Metabolism—SLC19A1—urinary bladder cancer	0.000338	0.00145	CbGpPWpGaD
Indapamide—Stomatitis—Doxorubicin—urinary bladder cancer	0.000337	0.000586	CcSEcCtD
Indapamide—Jaundice—Doxorubicin—urinary bladder cancer	0.000337	0.000586	CcSEcCtD
Indapamide—Rhinitis—Epirubicin—urinary bladder cancer	0.000336	0.000585	CcSEcCtD
Indapamide—Abdominal pain—Etoposide—urinary bladder cancer	0.000336	0.000585	CcSEcCtD
Indapamide—Body temperature increased—Etoposide—urinary bladder cancer	0.000336	0.000585	CcSEcCtD
Indapamide—Conjunctivitis—Doxorubicin—urinary bladder cancer	0.000336	0.000585	CcSEcCtD
Indapamide—Urinary tract infection—Doxorubicin—urinary bladder cancer	0.000336	0.000585	CcSEcCtD
Indapamide—Hepatitis—Epirubicin—urinary bladder cancer	0.000335	0.000584	CcSEcCtD
Indapamide—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000335	0.000583	CcSEcCtD
Indapamide—Tinnitus—Methotrexate—urinary bladder cancer	0.000334	0.000582	CcSEcCtD
Indapamide—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.000334	0.000581	CcSEcCtD
Indapamide—Asthenia—Cisplatin—urinary bladder cancer	0.000333	0.000579	CcSEcCtD
Indapamide—Pharyngitis—Epirubicin—urinary bladder cancer	0.000333	0.000579	CcSEcCtD
Indapamide—Cardiac disorder—Methotrexate—urinary bladder cancer	0.000333	0.000579	CcSEcCtD
Indapamide—Sweating—Doxorubicin—urinary bladder cancer	0.000331	0.000577	CcSEcCtD
Indapamide—Urinary tract disorder—Epirubicin—urinary bladder cancer	0.000331	0.000576	CcSEcCtD
Indapamide—Oedema peripheral—Epirubicin—urinary bladder cancer	0.00033	0.000575	CcSEcCtD
Indapamide—CA12—Metabolism—TYMP—urinary bladder cancer	0.00033	0.00142	CbGpPWpGaD
Indapamide—CA4—Metabolism—PRSS3—urinary bladder cancer	0.000329	0.00141	CbGpPWpGaD
Indapamide—Urethral disorder—Epirubicin—urinary bladder cancer	0.000329	0.000572	CcSEcCtD
Indapamide—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.000327	0.000569	CcSEcCtD
Indapamide—Sinusitis—Doxorubicin—urinary bladder cancer	0.000324	0.000564	CcSEcCtD
Indapamide—Dizziness—Fluorouracil—urinary bladder cancer	0.000324	0.000563	CcSEcCtD
Indapamide—CA2—Metabolism—SLC19A1—urinary bladder cancer	0.000324	0.00139	CbGpPWpGaD
Indapamide—Visual impairment—Epirubicin—urinary bladder cancer	0.000323	0.000562	CcSEcCtD
Indapamide—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.000323	0.000561	CcSEcCtD
Indapamide—CA7—Metabolism—NAT2—urinary bladder cancer	0.000322	0.00138	CbGpPWpGaD
Indapamide—CA5B—Metabolism—NAT2—urinary bladder cancer	0.000322	0.00138	CbGpPWpGaD
Indapamide—CA9—Metabolism—UGT2B7—urinary bladder cancer	0.000321	0.00138	CbGpPWpGaD
Indapamide—Diarrhoea—Cisplatin—urinary bladder cancer	0.000317	0.000553	CcSEcCtD
Indapamide—Erythema multiforme—Epirubicin—urinary bladder cancer	0.000317	0.000552	CcSEcCtD
Indapamide—Vomiting—Gemcitabine—urinary bladder cancer	0.000317	0.000551	CcSEcCtD
Indapamide—CYP3A4—Biological oxidations—UGT2B7—urinary bladder cancer	0.000316	0.00136	CbGpPWpGaD
Indapamide—CA2—Metabolism—PRSS3—urinary bladder cancer	0.000315	0.00136	CbGpPWpGaD
Indapamide—Rash—Gemcitabine—urinary bladder cancer	0.000314	0.000546	CcSEcCtD
Indapamide—Dermatitis—Gemcitabine—urinary bladder cancer	0.000314	0.000546	CcSEcCtD
Indapamide—Hypersensitivity—Etoposide—urinary bladder cancer	0.000313	0.000545	CcSEcCtD
Indapamide—Tinnitus—Epirubicin—urinary bladder cancer	0.000313	0.000544	CcSEcCtD
Indapamide—CA9—Cellular responses to stress—ATM—urinary bladder cancer	0.000312	0.00134	CbGpPWpGaD
Indapamide—Erythema—Methotrexate—urinary bladder cancer	0.000312	0.000543	CcSEcCtD
Indapamide—Malnutrition—Methotrexate—urinary bladder cancer	0.000312	0.000543	CcSEcCtD
Indapamide—Headache—Gemcitabine—urinary bladder cancer	0.000312	0.000543	CcSEcCtD
Indapamide—CYP3A4—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.000311	0.00134	CbGpPWpGaD
Indapamide—Flushing—Epirubicin—urinary bladder cancer	0.000311	0.000542	CcSEcCtD
Indapamide—Cardiac disorder—Epirubicin—urinary bladder cancer	0.000311	0.000542	CcSEcCtD
Indapamide—Vomiting—Fluorouracil—urinary bladder cancer	0.000311	0.000542	CcSEcCtD
Indapamide—Rhinitis—Doxorubicin—urinary bladder cancer	0.000311	0.000541	CcSEcCtD
Indapamide—CA9—Cellular responses to stress—CDK4—urinary bladder cancer	0.000311	0.00134	CbGpPWpGaD
Indapamide—Hepatitis—Doxorubicin—urinary bladder cancer	0.00031	0.00054	CcSEcCtD
Indapamide—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.000309	0.000537	CcSEcCtD
Indapamide—Rash—Fluorouracil—urinary bladder cancer	0.000309	0.000537	CcSEcCtD
Indapamide—Dermatitis—Fluorouracil—urinary bladder cancer	0.000308	0.000537	CcSEcCtD
Indapamide—Pharyngitis—Doxorubicin—urinary bladder cancer	0.000308	0.000536	CcSEcCtD
Indapamide—Headache—Fluorouracil—urinary bladder cancer	0.000307	0.000534	CcSEcCtD
Indapamide—Urinary tract disorder—Doxorubicin—urinary bladder cancer	0.000306	0.000533	CcSEcCtD
Indapamide—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.000306	0.000532	CcSEcCtD
Indapamide—Dysgeusia—Methotrexate—urinary bladder cancer	0.000306	0.000532	CcSEcCtD
Indapamide—Asthenia—Etoposide—urinary bladder cancer	0.000305	0.000531	CcSEcCtD
Indapamide—Urethral disorder—Doxorubicin—urinary bladder cancer	0.000304	0.000529	CcSEcCtD
Indapamide—Back pain—Methotrexate—urinary bladder cancer	0.000302	0.000525	CcSEcCtD
Indapamide—Pruritus—Etoposide—urinary bladder cancer	0.000301	0.000523	CcSEcCtD
Indapamide—Arrhythmia—Epirubicin—urinary bladder cancer	0.0003	0.000521	CcSEcCtD
Indapamide—Visual impairment—Doxorubicin—urinary bladder cancer	0.000299	0.00052	CcSEcCtD
Indapamide—CA12—Metabolism—NAT2—urinary bladder cancer	0.000298	0.00128	CbGpPWpGaD
Indapamide—CA5A—Metabolism—RRM2—urinary bladder cancer	0.000298	0.00128	CbGpPWpGaD
Indapamide—Nausea—Gemcitabine—urinary bladder cancer	0.000296	0.000515	CcSEcCtD
Indapamide—Vomiting—Cisplatin—urinary bladder cancer	0.000295	0.000513	CcSEcCtD
Indapamide—Vision blurred—Methotrexate—urinary bladder cancer	0.000294	0.000512	CcSEcCtD
Indapamide—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.000293	0.000511	CcSEcCtD
Indapamide—Rash—Cisplatin—urinary bladder cancer	0.000293	0.000509	CcSEcCtD
Indapamide—Dermatitis—Cisplatin—urinary bladder cancer	0.000292	0.000509	CcSEcCtD
Indapamide—Malnutrition—Epirubicin—urinary bladder cancer	0.000292	0.000508	CcSEcCtD
Indapamide—Erythema—Epirubicin—urinary bladder cancer	0.000292	0.000508	CcSEcCtD
Indapamide—Diarrhoea—Etoposide—urinary bladder cancer	0.000291	0.000506	CcSEcCtD
Indapamide—Nausea—Fluorouracil—urinary bladder cancer	0.000291	0.000506	CcSEcCtD
Indapamide—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000289	0.000504	CcSEcCtD
Indapamide—Tinnitus—Doxorubicin—urinary bladder cancer	0.000289	0.000504	CcSEcCtD
Indapamide—CA9—Metabolism—CYP4B1—urinary bladder cancer	0.000289	0.00124	CbGpPWpGaD
Indapamide—Anaemia—Methotrexate—urinary bladder cancer	0.000288	0.000502	CcSEcCtD
Indapamide—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.000288	0.000501	CcSEcCtD
Indapamide—Flushing—Doxorubicin—urinary bladder cancer	0.000288	0.000501	CcSEcCtD
Indapamide—Flatulence—Epirubicin—urinary bladder cancer	0.000288	0.000501	CcSEcCtD
Indapamide—Tension—Epirubicin—urinary bladder cancer	0.000287	0.000499	CcSEcCtD
Indapamide—Dysgeusia—Epirubicin—urinary bladder cancer	0.000286	0.000498	CcSEcCtD
Indapamide—CYP3A4—Biological oxidations—CYP4B1—urinary bladder cancer	0.000284	0.00122	CbGpPWpGaD
Indapamide—Nervousness—Epirubicin—urinary bladder cancer	0.000284	0.000493	CcSEcCtD
Indapamide—Back pain—Epirubicin—urinary bladder cancer	0.000282	0.000491	CcSEcCtD
Indapamide—Malaise—Methotrexate—urinary bladder cancer	0.000281	0.00049	CcSEcCtD
Indapamide—Dizziness—Etoposide—urinary bladder cancer	0.000281	0.000489	CcSEcCtD
Indapamide—Muscle spasms—Epirubicin—urinary bladder cancer	0.000281	0.000489	CcSEcCtD
Indapamide—CYP3A4—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.00028	0.00121	CbGpPWpGaD
Indapamide—Vertigo—Methotrexate—urinary bladder cancer	0.00028	0.000488	CcSEcCtD
Indapamide—Leukopenia—Methotrexate—urinary bladder cancer	0.000279	0.000486	CcSEcCtD
Indapamide—CA7—Metabolism—RRM2—urinary bladder cancer	0.000278	0.00119	CbGpPWpGaD
Indapamide—CA5B—Metabolism—RRM2—urinary bladder cancer	0.000278	0.00119	CbGpPWpGaD
Indapamide—Arrhythmia—Doxorubicin—urinary bladder cancer	0.000277	0.000482	CcSEcCtD
Indapamide—CA5A—Metabolism—ENO2—urinary bladder cancer	0.000276	0.00119	CbGpPWpGaD
Indapamide—CA5A—Metabolism—HPGDS—urinary bladder cancer	0.000276	0.00119	CbGpPWpGaD
Indapamide—Nausea—Cisplatin—urinary bladder cancer	0.000276	0.00048	CcSEcCtD
Indapamide—Vision blurred—Epirubicin—urinary bladder cancer	0.000275	0.000479	CcSEcCtD
Indapamide—CA9—Metabolism—SLC19A1—urinary bladder cancer	0.000273	0.00117	CbGpPWpGaD
Indapamide—Cough—Methotrexate—urinary bladder cancer	0.000272	0.000474	CcSEcCtD
Indapamide—CA9—Cellular responses to stress—CREBBP—urinary bladder cancer	0.000271	0.00117	CbGpPWpGaD
Indapamide—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000271	0.000471	CcSEcCtD
Indapamide—Vomiting—Etoposide—urinary bladder cancer	0.00027	0.00047	CcSEcCtD
Indapamide—CA9—Cellular responses to stress—RB1—urinary bladder cancer	0.00027	0.00116	CbGpPWpGaD
Indapamide—Malnutrition—Doxorubicin—urinary bladder cancer	0.00027	0.00047	CcSEcCtD
Indapamide—Erythema—Doxorubicin—urinary bladder cancer	0.00027	0.00047	CcSEcCtD
Indapamide—Anaemia—Epirubicin—urinary bladder cancer	0.00027	0.00047	CcSEcCtD
Indapamide—Agitation—Epirubicin—urinary bladder cancer	0.000268	0.000467	CcSEcCtD
Indapamide—Rash—Etoposide—urinary bladder cancer	0.000268	0.000466	CcSEcCtD
Indapamide—Dermatitis—Etoposide—urinary bladder cancer	0.000268	0.000466	CcSEcCtD
Indapamide—CA5A—Metabolism—GSTT1—urinary bladder cancer	0.000267	0.00115	CbGpPWpGaD
Indapamide—Headache—Etoposide—urinary bladder cancer	0.000266	0.000463	CcSEcCtD
Indapamide—Flatulence—Doxorubicin—urinary bladder cancer	0.000266	0.000463	CcSEcCtD
Indapamide—CA9—Metabolism—PRSS3—urinary bladder cancer	0.000266	0.00114	CbGpPWpGaD
Indapamide—Chest pain—Methotrexate—urinary bladder cancer	0.000266	0.000462	CcSEcCtD
Indapamide—Arthralgia—Methotrexate—urinary bladder cancer	0.000266	0.000462	CcSEcCtD
Indapamide—Myalgia—Methotrexate—urinary bladder cancer	0.000266	0.000462	CcSEcCtD
Indapamide—Tension—Doxorubicin—urinary bladder cancer	0.000265	0.000461	CcSEcCtD
Indapamide—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000265	0.00046	CcSEcCtD
Indapamide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000264	0.000459	CcSEcCtD
Indapamide—Malaise—Epirubicin—urinary bladder cancer	0.000263	0.000458	CcSEcCtD
Indapamide—CA4—Metabolism—TYMP—urinary bladder cancer	0.000263	0.00113	CbGpPWpGaD
Indapamide—Discomfort—Methotrexate—urinary bladder cancer	0.000262	0.000457	CcSEcCtD
Indapamide—Nervousness—Doxorubicin—urinary bladder cancer	0.000262	0.000457	CcSEcCtD
Indapamide—Vertigo—Epirubicin—urinary bladder cancer	0.000262	0.000457	CcSEcCtD
Indapamide—KCNQ1—Neuronal System—HRAS—urinary bladder cancer	0.000262	0.00113	CbGpPWpGaD
Indapamide—Syncope—Epirubicin—urinary bladder cancer	0.000262	0.000456	CcSEcCtD
Indapamide—Leukopenia—Epirubicin—urinary bladder cancer	0.000261	0.000455	CcSEcCtD
Indapamide—Back pain—Doxorubicin—urinary bladder cancer	0.000261	0.000455	CcSEcCtD
Indapamide—Muscle spasms—Doxorubicin—urinary bladder cancer	0.00026	0.000452	CcSEcCtD
Indapamide—Palpitations—Epirubicin—urinary bladder cancer	0.000258	0.000449	CcSEcCtD
Indapamide—CA12—Metabolism—RRM2—urinary bladder cancer	0.000257	0.00111	CbGpPWpGaD
Indapamide—CA5B—Metabolism—HPGDS—urinary bladder cancer	0.000257	0.00111	CbGpPWpGaD
Indapamide—CA7—Metabolism—HPGDS—urinary bladder cancer	0.000257	0.00111	CbGpPWpGaD
Indapamide—CA7—Metabolism—ENO2—urinary bladder cancer	0.000257	0.00111	CbGpPWpGaD
Indapamide—CA5B—Metabolism—ENO2—urinary bladder cancer	0.000257	0.00111	CbGpPWpGaD
Indapamide—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000257	0.000447	CcSEcCtD
Indapamide—Cough—Epirubicin—urinary bladder cancer	0.000255	0.000443	CcSEcCtD
Indapamide—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000255	0.000443	CcSEcCtD
Indapamide—Vision blurred—Doxorubicin—urinary bladder cancer	0.000255	0.000443	CcSEcCtD
Indapamide—Infection—Methotrexate—urinary bladder cancer	0.000253	0.00044	CcSEcCtD
Indapamide—Nausea—Etoposide—urinary bladder cancer	0.000252	0.000439	CcSEcCtD
Indapamide—CA2—Metabolism—TYMP—urinary bladder cancer	0.000252	0.00108	CbGpPWpGaD
Indapamide—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000251	0.000436	CcSEcCtD
Indapamide—Nervous system disorder—Methotrexate—urinary bladder cancer	0.00025	0.000435	CcSEcCtD
Indapamide—Anaemia—Doxorubicin—urinary bladder cancer	0.00025	0.000435	CcSEcCtD
Indapamide—CA7—Metabolism—GSTT1—urinary bladder cancer	0.00025	0.00107	CbGpPWpGaD
Indapamide—CA5B—Metabolism—GSTT1—urinary bladder cancer	0.00025	0.00107	CbGpPWpGaD
Indapamide—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000249	0.000434	CcSEcCtD
Indapamide—Chest pain—Epirubicin—urinary bladder cancer	0.000249	0.000433	CcSEcCtD
Indapamide—Myalgia—Epirubicin—urinary bladder cancer	0.000249	0.000433	CcSEcCtD
Indapamide—Arthralgia—Epirubicin—urinary bladder cancer	0.000249	0.000433	CcSEcCtD
Indapamide—Agitation—Doxorubicin—urinary bladder cancer	0.000248	0.000432	CcSEcCtD
Indapamide—Anxiety—Epirubicin—urinary bladder cancer	0.000248	0.000431	CcSEcCtD
Indapamide—Skin disorder—Methotrexate—urinary bladder cancer	0.000247	0.00043	CcSEcCtD
Indapamide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000247	0.00043	CcSEcCtD
Indapamide—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000246	0.000428	CcSEcCtD
Indapamide—Discomfort—Epirubicin—urinary bladder cancer	0.000246	0.000427	CcSEcCtD
Indapamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.000245	0.00105	CbGpPWpGaD
Indapamide—Malaise—Doxorubicin—urinary bladder cancer	0.000244	0.000424	CcSEcCtD
Indapamide—Dry mouth—Epirubicin—urinary bladder cancer	0.000243	0.000423	CcSEcCtD
Indapamide—Vertigo—Doxorubicin—urinary bladder cancer	0.000243	0.000422	CcSEcCtD
Indapamide—Anorexia—Methotrexate—urinary bladder cancer	0.000243	0.000422	CcSEcCtD
Indapamide—Syncope—Doxorubicin—urinary bladder cancer	0.000242	0.000422	CcSEcCtD
Indapamide—Leukopenia—Doxorubicin—urinary bladder cancer	0.000242	0.000421	CcSEcCtD
Indapamide—Palpitations—Doxorubicin—urinary bladder cancer	0.000239	0.000415	CcSEcCtD
Indapamide—CA12—Metabolism—ENO2—urinary bladder cancer	0.000238	0.00103	CbGpPWpGaD
Indapamide—CA12—Metabolism—HPGDS—urinary bladder cancer	0.000238	0.00103	CbGpPWpGaD
Indapamide—Oedema—Epirubicin—urinary bladder cancer	0.000238	0.000415	CcSEcCtD
Indapamide—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000238	0.000415	CcSEcCtD
Indapamide—Hypotension—Methotrexate—urinary bladder cancer	0.000238	0.000414	CcSEcCtD
Indapamide—CA4—Metabolism—NAT2—urinary bladder cancer	0.000238	0.00102	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—CDKN2A—urinary bladder cancer	0.000238	0.00102	CbGpPWpGaD
Indapamide—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000237	0.000413	CcSEcCtD
Indapamide—Infection—Epirubicin—urinary bladder cancer	0.000237	0.000412	CcSEcCtD
Indapamide—Cough—Doxorubicin—urinary bladder cancer	0.000236	0.00041	CcSEcCtD
Indapamide—Shock—Epirubicin—urinary bladder cancer	0.000234	0.000408	CcSEcCtD
Indapamide—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000234	0.000407	CcSEcCtD
Indapamide—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000233	0.000406	CcSEcCtD
Indapamide—Tachycardia—Epirubicin—urinary bladder cancer	0.000233	0.000405	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000232	0.000404	CcSEcCtD
Indapamide—Skin disorder—Epirubicin—urinary bladder cancer	0.000231	0.000403	CcSEcCtD
Indapamide—CA12—Metabolism—GSTT1—urinary bladder cancer	0.000231	0.000994	CbGpPWpGaD
Indapamide—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.00023	0.000401	CcSEcCtD
Indapamide—Insomnia—Methotrexate—urinary bladder cancer	0.00023	0.000401	CcSEcCtD
Indapamide—Chest pain—Doxorubicin—urinary bladder cancer	0.00023	0.0004	CcSEcCtD
Indapamide—Arthralgia—Doxorubicin—urinary bladder cancer	0.00023	0.0004	CcSEcCtD
Indapamide—Myalgia—Doxorubicin—urinary bladder cancer	0.00023	0.0004	CcSEcCtD
Indapamide—Anxiety—Doxorubicin—urinary bladder cancer	0.000229	0.000399	CcSEcCtD
Indapamide—Paraesthesia—Methotrexate—urinary bladder cancer	0.000229	0.000398	CcSEcCtD
Indapamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000228	0.000397	CcSEcCtD
Indapamide—CA2—Metabolism—NAT2—urinary bladder cancer	0.000228	0.00098	CbGpPWpGaD
Indapamide—Discomfort—Doxorubicin—urinary bladder cancer	0.000227	0.000395	CcSEcCtD
Indapamide—Anorexia—Epirubicin—urinary bladder cancer	0.000227	0.000395	CcSEcCtD
Indapamide—Dyspnoea—Methotrexate—urinary bladder cancer	0.000227	0.000395	CcSEcCtD
Indapamide—Somnolence—Methotrexate—urinary bladder cancer	0.000226	0.000394	CcSEcCtD
Indapamide—Dry mouth—Doxorubicin—urinary bladder cancer	0.000225	0.000391	CcSEcCtD
Indapamide—Dyspepsia—Methotrexate—urinary bladder cancer	0.000224	0.00039	CcSEcCtD
Indapamide—Hypotension—Epirubicin—urinary bladder cancer	0.000223	0.000387	CcSEcCtD
Indapamide—CA5A—Metabolism—NQO1—urinary bladder cancer	0.000222	0.000955	CbGpPWpGaD
Indapamide—Decreased appetite—Methotrexate—urinary bladder cancer	0.000221	0.000385	CcSEcCtD
Indapamide—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.00022	0.000384	CcSEcCtD
Indapamide—Oedema—Doxorubicin—urinary bladder cancer	0.00022	0.000384	CcSEcCtD
Indapamide—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.00022	0.000383	CcSEcCtD
Indapamide—Fatigue—Methotrexate—urinary bladder cancer	0.00022	0.000382	CcSEcCtD
Indapamide—Infection—Doxorubicin—urinary bladder cancer	0.000219	0.000381	CcSEcCtD
Indapamide—Pain—Methotrexate—urinary bladder cancer	0.000218	0.000379	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000217	0.000378	CcSEcCtD
Indapamide—Shock—Doxorubicin—urinary bladder cancer	0.000217	0.000377	CcSEcCtD
Indapamide—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000216	0.000376	CcSEcCtD
Indapamide—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000216	0.000376	CcSEcCtD
Indapamide—Insomnia—Epirubicin—urinary bladder cancer	0.000216	0.000375	CcSEcCtD
Indapamide—CA9—Cellular responses to stress—CXCL8—urinary bladder cancer	0.000215	0.000926	CbGpPWpGaD
Indapamide—Tachycardia—Doxorubicin—urinary bladder cancer	0.000215	0.000374	CcSEcCtD
Indapamide—Skin disorder—Doxorubicin—urinary bladder cancer	0.000214	0.000373	CcSEcCtD
Indapamide—Paraesthesia—Epirubicin—urinary bladder cancer	0.000214	0.000372	CcSEcCtD
Indapamide—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000213	0.000371	CcSEcCtD
Indapamide—CA9—Metabolism—TYMP—urinary bladder cancer	0.000213	0.000914	CbGpPWpGaD
Indapamide—Dyspnoea—Epirubicin—urinary bladder cancer	0.000212	0.00037	CcSEcCtD
Indapamide—Somnolence—Epirubicin—urinary bladder cancer	0.000212	0.000369	CcSEcCtD
Indapamide—Anorexia—Doxorubicin—urinary bladder cancer	0.00021	0.000366	CcSEcCtD
Indapamide—Feeling abnormal—Methotrexate—urinary bladder cancer	0.00021	0.000365	CcSEcCtD
Indapamide—Dyspepsia—Epirubicin—urinary bladder cancer	0.00021	0.000365	CcSEcCtD
Indapamide—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000208	0.000362	CcSEcCtD
Indapamide—CA5B—Metabolism—NQO1—urinary bladder cancer	0.000207	0.000892	CbGpPWpGaD
Indapamide—CA7—Metabolism—NQO1—urinary bladder cancer	0.000207	0.000892	CbGpPWpGaD
Indapamide—Decreased appetite—Epirubicin—urinary bladder cancer	0.000207	0.00036	CcSEcCtD
Indapamide—Hypotension—Doxorubicin—urinary bladder cancer	0.000206	0.000359	CcSEcCtD
Indapamide—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000206	0.000358	CcSEcCtD
Indapamide—Fatigue—Epirubicin—urinary bladder cancer	0.000205	0.000358	CcSEcCtD
Indapamide—CA4—Metabolism—RRM2—urinary bladder cancer	0.000205	0.000883	CbGpPWpGaD
Indapamide—Pain—Epirubicin—urinary bladder cancer	0.000204	0.000355	CcSEcCtD
Indapamide—Constipation—Epirubicin—urinary bladder cancer	0.000204	0.000355	CcSEcCtD
Indapamide—Urticaria—Methotrexate—urinary bladder cancer	0.000202	0.000352	CcSEcCtD
Indapamide—Abdominal pain—Methotrexate—urinary bladder cancer	0.000201	0.00035	CcSEcCtD
Indapamide—Body temperature increased—Methotrexate—urinary bladder cancer	0.000201	0.00035	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000201	0.00035	CcSEcCtD
Indapamide—SLC12A3—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	0.0002	0.00086	CbGpPWpGaD
Indapamide—Insomnia—Doxorubicin—urinary bladder cancer	0.000199	0.000347	CcSEcCtD
Indapamide—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000198	0.000345	CcSEcCtD
Indapamide—CA2—Metabolism—RRM2—urinary bladder cancer	0.000197	0.000846	CbGpPWpGaD
Indapamide—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000197	0.000342	CcSEcCtD
Indapamide—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000196	0.000342	CcSEcCtD
Indapamide—Somnolence—Doxorubicin—urinary bladder cancer	0.000196	0.000341	CcSEcCtD
Indapamide—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000195	0.000339	CcSEcCtD
Indapamide—CA9—Cellular responses to stress—CDKN1A—urinary bladder cancer	0.000194	0.000835	CbGpPWpGaD
Indapamide—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000194	0.000338	CcSEcCtD
Indapamide—CA12—Metabolism—NQO1—urinary bladder cancer	0.000192	0.000826	CbGpPWpGaD
Indapamide—CA9—Metabolism—NAT2—urinary bladder cancer	0.000192	0.000826	CbGpPWpGaD
Indapamide—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000192	0.000334	CcSEcCtD
Indapamide—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.00019	0.000331	CcSEcCtD
Indapamide—CA4—Metabolism—ENO2—urinary bladder cancer	0.00019	0.000817	CbGpPWpGaD
Indapamide—CA4—Metabolism—HPGDS—urinary bladder cancer	0.00019	0.000817	CbGpPWpGaD
Indapamide—Fatigue—Doxorubicin—urinary bladder cancer	0.00019	0.000331	CcSEcCtD
Indapamide—Urticaria—Epirubicin—urinary bladder cancer	0.000189	0.000329	CcSEcCtD
Indapamide—CYP3A4—Biological oxidations—NAT2—urinary bladder cancer	0.000189	0.000813	CbGpPWpGaD
Indapamide—Pain—Doxorubicin—urinary bladder cancer	0.000189	0.000328	CcSEcCtD
Indapamide—Constipation—Doxorubicin—urinary bladder cancer	0.000189	0.000328	CcSEcCtD
Indapamide—Abdominal pain—Epirubicin—urinary bladder cancer	0.000188	0.000328	CcSEcCtD
Indapamide—Body temperature increased—Epirubicin—urinary bladder cancer	0.000188	0.000328	CcSEcCtD
Indapamide—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000188	0.000326	CcSEcCtD
Indapamide—CYP3A4—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000187	0.000802	CbGpPWpGaD
Indapamide—CA5A—Metabolism—GSTP1—urinary bladder cancer	0.000185	0.000797	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—EP300—urinary bladder cancer	0.000185	0.000794	CbGpPWpGaD
Indapamide—CA4—Metabolism—GSTT1—urinary bladder cancer	0.000184	0.000793	CbGpPWpGaD
Indapamide—Asthenia—Methotrexate—urinary bladder cancer	0.000183	0.000318	CcSEcCtD
Indapamide—CA2—Metabolism—HPGDS—urinary bladder cancer	0.000182	0.000784	CbGpPWpGaD
Indapamide—CA2—Metabolism—ENO2—urinary bladder cancer	0.000182	0.000784	CbGpPWpGaD
Indapamide—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000182	0.000316	CcSEcCtD
Indapamide—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.00018	0.000314	CcSEcCtD
Indapamide—Pruritus—Methotrexate—urinary bladder cancer	0.00018	0.000314	CcSEcCtD
Indapamide—CA2—Metabolism—GSTT1—urinary bladder cancer	0.000177	0.00076	CbGpPWpGaD
Indapamide—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000176	0.000306	CcSEcCtD
Indapamide—Urticaria—Doxorubicin—urinary bladder cancer	0.000175	0.000305	CcSEcCtD
Indapamide—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000174	0.000303	CcSEcCtD
Indapamide—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000174	0.000303	CcSEcCtD
Indapamide—Diarrhoea—Methotrexate—urinary bladder cancer	0.000174	0.000303	CcSEcCtD
Indapamide—CA5B—Metabolism—GSTP1—urinary bladder cancer	0.000173	0.000744	CbGpPWpGaD
Indapamide—CA7—Metabolism—GSTP1—urinary bladder cancer	0.000173	0.000744	CbGpPWpGaD
Indapamide—CA5A—Metabolism—TYMS—urinary bladder cancer	0.000172	0.000741	CbGpPWpGaD
Indapamide—Asthenia—Epirubicin—urinary bladder cancer	0.000171	0.000298	CcSEcCtD
Indapamide—CA5A—Metabolism—GSTM1—urinary bladder cancer	0.00017	0.000732	CbGpPWpGaD
Indapamide—CA5A—Metabolism—NCOR1—urinary bladder cancer	0.00017	0.000732	CbGpPWpGaD
Indapamide—Pruritus—Epirubicin—urinary bladder cancer	0.000169	0.000293	CcSEcCtD
Indapamide—Dizziness—Methotrexate—urinary bladder cancer	0.000168	0.000293	CcSEcCtD
Indapamide—CA9—Metabolism—RRM2—urinary bladder cancer	0.000166	0.000713	CbGpPWpGaD
Indapamide—CA5A—Metabolism—GPX1—urinary bladder cancer	0.000163	0.000701	CbGpPWpGaD
Indapamide—Diarrhoea—Epirubicin—urinary bladder cancer	0.000163	0.000284	CcSEcCtD
Indapamide—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000162	0.000283	CcSEcCtD
Indapamide—Vomiting—Methotrexate—urinary bladder cancer	0.000162	0.000282	CcSEcCtD
Indapamide—CA5B—Metabolism—TYMS—urinary bladder cancer	0.000161	0.000692	CbGpPWpGaD
Indapamide—CA7—Metabolism—TYMS—urinary bladder cancer	0.000161	0.000692	CbGpPWpGaD
Indapamide—Rash—Methotrexate—urinary bladder cancer	0.000161	0.000279	CcSEcCtD
Indapamide—Dermatitis—Methotrexate—urinary bladder cancer	0.00016	0.000279	CcSEcCtD
Indapamide—CA12—Metabolism—GSTP1—urinary bladder cancer	0.00016	0.000689	CbGpPWpGaD
Indapamide—CA5A—Metabolism—ERCC2—urinary bladder cancer	0.00016	0.000688	CbGpPWpGaD
Indapamide—Headache—Methotrexate—urinary bladder cancer	0.00016	0.000278	CcSEcCtD
Indapamide—CA7—Metabolism—GSTM1—urinary bladder cancer	0.000159	0.000684	CbGpPWpGaD
Indapamide—CA5B—Metabolism—NCOR1—urinary bladder cancer	0.000159	0.000684	CbGpPWpGaD
Indapamide—CA5B—Metabolism—GSTM1—urinary bladder cancer	0.000159	0.000684	CbGpPWpGaD
Indapamide—CA7—Metabolism—NCOR1—urinary bladder cancer	0.000159	0.000684	CbGpPWpGaD
Indapamide—Asthenia—Doxorubicin—urinary bladder cancer	0.000158	0.000275	CcSEcCtD
Indapamide—Dizziness—Epirubicin—urinary bladder cancer	0.000158	0.000274	CcSEcCtD
Indapamide—Pruritus—Doxorubicin—urinary bladder cancer	0.000156	0.000271	CcSEcCtD
Indapamide—CA9—Metabolism—ENO2—urinary bladder cancer	0.000154	0.000661	CbGpPWpGaD
Indapamide—CA9—Metabolism—HPGDS—urinary bladder cancer	0.000154	0.000661	CbGpPWpGaD
Indapamide—CA4—Metabolism—NQO1—urinary bladder cancer	0.000153	0.000659	CbGpPWpGaD
Indapamide—CA7—Metabolism—GPX1—urinary bladder cancer	0.000152	0.000655	CbGpPWpGaD
Indapamide—CA5B—Metabolism—GPX1—urinary bladder cancer	0.000152	0.000655	CbGpPWpGaD
Indapamide—Vomiting—Epirubicin—urinary bladder cancer	0.000152	0.000264	CcSEcCtD
Indapamide—Nausea—Methotrexate—urinary bladder cancer	0.000151	0.000263	CcSEcCtD
Indapamide—CYP3A4—Biological oxidations—HPGDS—urinary bladder cancer	0.000151	0.00065	CbGpPWpGaD
Indapamide—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000151	0.000263	CcSEcCtD
Indapamide—CA5A—Metabolism—MTHFR—urinary bladder cancer	0.000151	0.000647	CbGpPWpGaD
Indapamide—Rash—Epirubicin—urinary bladder cancer	0.00015	0.000261	CcSEcCtD
Indapamide—Dermatitis—Epirubicin—urinary bladder cancer	0.00015	0.000261	CcSEcCtD
Indapamide—CA5B—Metabolism—ERCC2—urinary bladder cancer	0.000149	0.000643	CbGpPWpGaD
Indapamide—CA7—Metabolism—ERCC2—urinary bladder cancer	0.000149	0.000643	CbGpPWpGaD
Indapamide—Headache—Epirubicin—urinary bladder cancer	0.000149	0.00026	CcSEcCtD
Indapamide—CA12—Metabolism—TYMS—urinary bladder cancer	0.000149	0.000641	CbGpPWpGaD
Indapamide—CA9—Metabolism—GSTT1—urinary bladder cancer	0.000149	0.000641	CbGpPWpGaD
Indapamide—CA12—Metabolism—GSTM1—urinary bladder cancer	0.000147	0.000633	CbGpPWpGaD
Indapamide—CA12—Metabolism—NCOR1—urinary bladder cancer	0.000147	0.000633	CbGpPWpGaD
Indapamide—CA2—Metabolism—NQO1—urinary bladder cancer	0.000147	0.000632	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—GSTT1—urinary bladder cancer	0.000147	0.000631	CbGpPWpGaD
Indapamide—Dizziness—Doxorubicin—urinary bladder cancer	0.000146	0.000254	CcSEcCtD
Indapamide—Nausea—Epirubicin—urinary bladder cancer	0.000142	0.000246	CcSEcCtD
Indapamide—CA12—Metabolism—GPX1—urinary bladder cancer	0.000141	0.000606	CbGpPWpGaD
Indapamide—CA7—Metabolism—MTHFR—urinary bladder cancer	0.000141	0.000604	CbGpPWpGaD
Indapamide—CA5B—Metabolism—MTHFR—urinary bladder cancer	0.000141	0.000604	CbGpPWpGaD
Indapamide—Vomiting—Doxorubicin—urinary bladder cancer	0.00014	0.000244	CcSEcCtD
Indapamide—Rash—Doxorubicin—urinary bladder cancer	0.000139	0.000242	CcSEcCtD
Indapamide—Dermatitis—Doxorubicin—urinary bladder cancer	0.000139	0.000242	CcSEcCtD
Indapamide—CA12—Metabolism—ERCC2—urinary bladder cancer	0.000138	0.000595	CbGpPWpGaD
Indapamide—Headache—Doxorubicin—urinary bladder cancer	0.000138	0.00024	CcSEcCtD
Indapamide—CA9—Cellular responses to stress—TP53—urinary bladder cancer	0.000132	0.000568	CbGpPWpGaD
Indapamide—Nausea—Doxorubicin—urinary bladder cancer	0.000131	0.000228	CcSEcCtD
Indapamide—CA12—Metabolism—MTHFR—urinary bladder cancer	0.00013	0.00056	CbGpPWpGaD
Indapamide—CA4—Metabolism—GSTP1—urinary bladder cancer	0.000128	0.00055	CbGpPWpGaD
Indapamide—CA9—Metabolism—NQO1—urinary bladder cancer	0.000124	0.000532	CbGpPWpGaD
Indapamide—CA2—Metabolism—GSTP1—urinary bladder cancer	0.000123	0.000527	CbGpPWpGaD
Indapamide—CA5A—Metabolism—PPARG—urinary bladder cancer	0.000122	0.000525	CbGpPWpGaD
Indapamide—CA4—Metabolism—TYMS—urinary bladder cancer	0.000119	0.000511	CbGpPWpGaD
Indapamide—CA4—Metabolism—NCOR1—urinary bladder cancer	0.000117	0.000505	CbGpPWpGaD
Indapamide—CA4—Metabolism—GSTM1—urinary bladder cancer	0.000117	0.000505	CbGpPWpGaD
Indapamide—CA5A—Metabolism—CREBBP—urinary bladder cancer	0.000117	0.000504	CbGpPWpGaD
Indapamide—CA7—Metabolism—PPARG—urinary bladder cancer	0.000114	0.00049	CbGpPWpGaD
Indapamide—CA5B—Metabolism—PPARG—urinary bladder cancer	0.000114	0.00049	CbGpPWpGaD
Indapamide—CA2—Metabolism—TYMS—urinary bladder cancer	0.000114	0.00049	CbGpPWpGaD
Indapamide—CA2—Metabolism—NCOR1—urinary bladder cancer	0.000113	0.000484	CbGpPWpGaD
Indapamide—CA2—Metabolism—GSTM1—urinary bladder cancer	0.000113	0.000484	CbGpPWpGaD
Indapamide—CA4—Metabolism—GPX1—urinary bladder cancer	0.000112	0.000484	CbGpPWpGaD
Indapamide—CA4—Metabolism—ERCC2—urinary bladder cancer	0.00011	0.000475	CbGpPWpGaD
Indapamide—CA5B—Metabolism—CREBBP—urinary bladder cancer	0.000109	0.000471	CbGpPWpGaD
Indapamide—CA7—Metabolism—CREBBP—urinary bladder cancer	0.000109	0.000471	CbGpPWpGaD
Indapamide—CA2—Metabolism—GPX1—urinary bladder cancer	0.000108	0.000464	CbGpPWpGaD
Indapamide—CA2—Metabolism—ERCC2—urinary bladder cancer	0.000106	0.000455	CbGpPWpGaD
Indapamide—CA12—Metabolism—PPARG—urinary bladder cancer	0.000106	0.000454	CbGpPWpGaD
Indapamide—CA4—Metabolism—MTHFR—urinary bladder cancer	0.000104	0.000446	CbGpPWpGaD
Indapamide—CA9—Metabolism—GSTP1—urinary bladder cancer	0.000103	0.000444	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	0.000102	0.000437	CbGpPWpGaD
Indapamide—CA12—Metabolism—CREBBP—urinary bladder cancer	0.000101	0.000436	CbGpPWpGaD
Indapamide—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.0001	0.000431	CbGpPWpGaD
Indapamide—CA2—Metabolism—MTHFR—urinary bladder cancer	9.95e-05	0.000428	CbGpPWpGaD
Indapamide—CA9—Metabolism—TYMS—urinary bladder cancer	9.6e-05	0.000413	CbGpPWpGaD
Indapamide—CA5A—Metabolism—PTGS2—urinary bladder cancer	9.6e-05	0.000413	CbGpPWpGaD
Indapamide—CA9—Metabolism—NCOR1—urinary bladder cancer	9.49e-05	0.000408	CbGpPWpGaD
Indapamide—CA9—Metabolism—GSTM1—urinary bladder cancer	9.49e-05	0.000408	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	9.34e-05	0.000402	CbGpPWpGaD
Indapamide—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	9.22e-05	0.000396	CbGpPWpGaD
Indapamide—CA9—Metabolism—GPX1—urinary bladder cancer	9.09e-05	0.000391	CbGpPWpGaD
Indapamide—CA7—Metabolism—PTGS2—urinary bladder cancer	8.96e-05	0.000385	CbGpPWpGaD
Indapamide—CA5B—Metabolism—PTGS2—urinary bladder cancer	8.96e-05	0.000385	CbGpPWpGaD
Indapamide—CA9—Metabolism—ERCC2—urinary bladder cancer	8.92e-05	0.000384	CbGpPWpGaD
Indapamide—CA4—Metabolism—PPARG—urinary bladder cancer	8.42e-05	0.000362	CbGpPWpGaD
Indapamide—CA9—Metabolism—MTHFR—urinary bladder cancer	8.39e-05	0.000361	CbGpPWpGaD
Indapamide—CA5A—Metabolism—PTEN—urinary bladder cancer	8.37e-05	0.00036	CbGpPWpGaD
Indapamide—CA12—Metabolism—PTGS2—urinary bladder cancer	8.3e-05	0.000357	CbGpPWpGaD
Indapamide—CA4—Metabolism—CREBBP—urinary bladder cancer	8.09e-05	0.000348	CbGpPWpGaD
Indapamide—CA2—Metabolism—PPARG—urinary bladder cancer	8.07e-05	0.000347	CbGpPWpGaD
Indapamide—CA5A—Metabolism—EP300—urinary bladder cancer	7.99e-05	0.000343	CbGpPWpGaD
Indapamide—CA5B—Metabolism—PTEN—urinary bladder cancer	7.82e-05	0.000336	CbGpPWpGaD
Indapamide—CA7—Metabolism—PTEN—urinary bladder cancer	7.82e-05	0.000336	CbGpPWpGaD
Indapamide—CA2—Metabolism—CREBBP—urinary bladder cancer	7.75e-05	0.000333	CbGpPWpGaD
Indapamide—CA5B—Metabolism—EP300—urinary bladder cancer	7.45e-05	0.000321	CbGpPWpGaD
Indapamide—CA7—Metabolism—EP300—urinary bladder cancer	7.45e-05	0.000321	CbGpPWpGaD
Indapamide—CA12—Metabolism—PTEN—urinary bladder cancer	7.24e-05	0.000311	CbGpPWpGaD
Indapamide—CA12—Metabolism—EP300—urinary bladder cancer	6.91e-05	0.000297	CbGpPWpGaD
Indapamide—CA9—Metabolism—PPARG—urinary bladder cancer	6.8e-05	0.000292	CbGpPWpGaD
Indapamide—CA4—Metabolism—PTGS2—urinary bladder cancer	6.62e-05	0.000285	CbGpPWpGaD
Indapamide—CA9—Metabolism—CREBBP—urinary bladder cancer	6.53e-05	0.000281	CbGpPWpGaD
Indapamide—CA2—Metabolism—PTGS2—urinary bladder cancer	6.35e-05	0.000273	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	6.23e-05	0.000268	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	5.9e-05	0.000254	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—NAT1—urinary bladder cancer	5.9e-05	0.000254	CbGpPWpGaD
Indapamide—CA4—Metabolism—PTEN—urinary bladder cancer	5.78e-05	0.000248	CbGpPWpGaD
Indapamide—CA2—Metabolism—PTEN—urinary bladder cancer	5.54e-05	0.000238	CbGpPWpGaD
Indapamide—CA4—Metabolism—EP300—urinary bladder cancer	5.51e-05	0.000237	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	5.4e-05	0.000232	CbGpPWpGaD
Indapamide—CA9—Metabolism—PTGS2—urinary bladder cancer	5.35e-05	0.00023	CbGpPWpGaD
Indapamide—CA2—Metabolism—EP300—urinary bladder cancer	5.28e-05	0.000227	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	4.86e-05	0.000209	CbGpPWpGaD
Indapamide—CA9—Metabolism—PTEN—urinary bladder cancer	4.67e-05	0.000201	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	4.59e-05	0.000197	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	4.47e-05	0.000192	CbGpPWpGaD
Indapamide—CA9—Metabolism—EP300—urinary bladder cancer	4.45e-05	0.000191	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—TYMP—urinary bladder cancer	3.58e-05	0.000154	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—NAT2—urinary bladder cancer	3.24e-05	0.000139	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—RRM2—urinary bladder cancer	2.79e-05	0.00012	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—ENO2—urinary bladder cancer	2.59e-05	0.000111	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	2.59e-05	0.000111	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	2.51e-05	0.000108	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—NQO1—urinary bladder cancer	2.08e-05	8.96e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	1.74e-05	7.48e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—TYMS—urinary bladder cancer	1.62e-05	6.95e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	1.6e-05	6.87e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	1.6e-05	6.87e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—GPX1—urinary bladder cancer	1.53e-05	6.58e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	1.5e-05	6.46e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	1.41e-05	6.07e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PPARG—urinary bladder cancer	1.15e-05	4.92e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	1.1e-05	4.73e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	9.01e-06	3.87e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PTEN—urinary bladder cancer	7.86e-06	3.38e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—EP300—urinary bladder cancer	7.49e-06	3.22e-05	CbGpPWpGaD
